CoChat

Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

The high failure rate of late-stage human clinical trials, particularly in oncology, predicates the need for improved translation of preclinical data from mouse tumor models into clinical predictions. Genetically engineered mouse models (GEMM) may fulfill this need, because they mimic spontaneous and autochthonous disease progression. Using oncogenic Kras-driven GEMMs of lung and pancreatic adenocarcinoma, we recently showed that these models can closely phenocopy human therapeutic responses to standard-of-care treatment regimens. Here we review the successful preclinical application of such GEMMs, as well as the potential for discovering predictive biomarkers and gaining mechanistic insights into clinical outcomes and drug resistance in human cancers. Cancer Res; 72(11); 2695–700. ©2012 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-2786

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 48 references

Cited by

See all 125

Metadata

Authors
Singh, M., Murriel, C. L., & Johnson, L.
Affiliations
Genentech (US)
Corresponding author
  • Singh, Mallika
  • Johnson, Leisa
Venue
Cancer Research
Published
2012-05-31
Volume
72
Issue
11
Pages
2695-2700
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2161869976
Cited by
125
References
48
Citations by year
2026: 4 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 9 · 2020: 14 · 2019: 8 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 15 · 2014: 12 · 2013: 17 · 2012: 3
FWCI
1.51
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
genetically engineered mouse models, translational oncology, KRAS-driven tumors, lung adenocarcinoma, pancreatic ductal adenocarcinoma, predictive biomarkers, drug resistance, preclinical to clinical translation, autochthonous tumor model, treatment response prediction
MeSH terms
Animals, Disease Models, Animal, Drug Evaluation, Preclinical, Genetic Engineering, Humans, Lung Neoplasms, Pancreatic Neoplasms, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), ras Proteins, Drug Resistance, Neoplasm, Vascular Endothelial Growth Factor A, Mice, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-2786
The paper
Singh, M., Murriel, C. L., & Johnson, L. (2012). Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-2786

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.